KPI THERAPEUTICS

kpi-therapeutics-logo

KPI Therapeutics is a healthcare company that connects initiative between drug development firms and private investors. The company believes that as an industry we can do better than develop just 20 to 30 new drugs per year. Our vision of KPI is to speed the progression of promising drug candidates through the critical translational stage of development and work with commercialization partners who have a strong commitment to improving access to important new medicines. It was founded in 2013 and headquartered in Seattle, Washington.

#People #Financial #Website #More

KPI THERAPEUTICS

Social Links:

Industry:
Health Care Medical Therapeutics

Founded:
2013-01-01

Address:
Seattle, Washington, United States

Country:
United States

Website Url:
http://www.kpitherapeutics.com

Total Employee:
11+

Status:
Closed

Contact:
(206) 378-0400

Total Funding:
77.5 K USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible WordPress Amazon AJAX Libraries API WordPress 6.0 GlobalSign Amazon California Region ClouDNS


Founder


charles-magness_image

Charles Magness

Investors List

keiretsu-capital_image

Keiretsu Capital

Keiretsu Capital investment in Venture Round - KPI Therapeutics

keiretsu-capital_image

Keiretsu Capital

Keiretsu Capital investment in Series A - KPI Therapeutics

angel-md_image

AngelMD

AngelMD investment in Series A - KPI Therapeutics

tsvcap_image

TSVC

TSVC investment in Series A - KPI Therapeutics

keiretsu-forum_image

Keiretsu Forum

Keiretsu Forum investment in Series A - KPI Therapeutics

Official Site Inspections

http://www.kpitherapeutics.com

  • Host name: lb-182-253.above.com
  • IP address: 103.224.182.253
  • Location: Australia
  • Latitude: -33.494
  • Longitude: 143.2104
  • Timezone: Australia/Sydney

Loading ...

More informations about "KPI Therapeutics"

KPI Therapeutics - Crunchbase Company Profile & Funding

KPI Therapeutics is a healthcare company that connects initiative between drug development firms and private investors.See details»

Dr. Dale Bredesen - Chief Science Officer At Apollo Health

An internationally recognized expert in the mechanisms of neurodegenerative diseases, Dr. Dale Bredesenโ€™s career has been guided by a simple idea: Alzheimerโ€™s as we know it is not just โ€ฆSee details»

KPI Therapeutics - PitchBook

Information on valuation, funding, cap tables, investors, and executives for KPI Therapeutics. Use the PitchBook Platform to explore the full profile.See details»

KPI Therapeutics - Funding, Financials, Valuation & Investors

KPI Therapeutics is a healthcare company that connects initiative between drug development firms and private investors.See details»

KPI Therapeutics, Inc. - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for KPI Therapeutics, Inc. of Seattle, WA. Get the latest business insights from Dun & Bradstreet.See details»

KPI Therapeutics - Crunchbase

KPI Therapeutics is a healthcare company that connects initiative between drug development firms and private investors.See details»

KPI Therapeutics, Inc. (KPI Therapeutics, Inc.) - ่ฏ็‰ฉ็ฎก็บฟ_ไธ“ๅˆฉ_ไธดๅบŠ โ€ฆ

The inflammatory myositis market is anticipated to surge owing to improvements in diagnosis over the globe and thus the surge in treatment options. In addition, the expected launch of โ€ฆSee details»

KPI Therapeutics - Products, Competitors, Financials, Employees ...

About KPI Therapeutics KPI Therapeutics, formerly Kineta, develops therapies backed by an alliance of development partners which drives focused, efficient drug development. The โ€ฆSee details»

KPI Therapeutics, Inc.: Drug pipelines, Patents, Clinical trials

Explore KPI Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 1 news, Disease Domain:Immune System Diseases, Technology Platform ...See details»

KPI Therapeutics - Company Profile - Tracxn

Nov 13, 2024 KPI Therapeutics - Small molecule drugs for autoimmune diseases and chronic pain indications. This company is not active anymore. Raised a total funding of $4.95M over 5 โ€ฆSee details»

Dr. Bredesen's Study - Muses Labs - ApoE4.Info

Nov 4, 2015 Muses Labs is also working on refining their protocol recccommendations (such as expanding their dietary recommendations) and improving their protocol reports. They are still โ€ฆSee details»

Biotech Consortium Launches KPI Therapeutics, Inc., a ... - Fierce โ€ฆ

Jun 9, 2014 Paul Sylvester, CFO of MPI Research, Inc., a global contract research organization, and KPI Board member stated, "We have enjoyed our existing partnership with Kineta and โ€ฆSee details»

Charles River Completes the Acquisition of MPI Research

Aug 22, 2018 MPI Research, a premier non-clinical contract research organization (CRO) providing comprehensive testing services to biopharmaceutical and medical device companies โ€ฆSee details»

An Interview with MPI Research - American Pharmaceutical Review

Jun 21, 2012 What sets MPI Research apart from competitors? MPI Research is the worldโ€™s largest single-site preclinical contract research organization with more than one million square โ€ฆSee details»

Therapeutics Initiative | Better prescribing. Better health.

Prescription drug therapy is a key element of medical care. The UBC Therapeutics Initiativeโ€™s goal is for drug therapies to be used wisely in the best interests of patients, based on thorough and โ€ฆSee details»

K36 Therapeutics - Crunchbase Company Profile & Funding

K36 Therapeutics translate epigenetic modulation of oncogenic pathways into small molecule therapies.See details»

MDI THERAPEUTICS, INC - VentureRadar

"MDI Therapeutics is a pharmaceutical company developing novel serpin-based therapies for the treatment of fibrosis and fibroproliferative disorders. The Company was founded on key โ€ฆSee details»

MDI Therapeutics - Crunchbase Company Profile & Funding

MDI Therapeutics is a operator of an discovery stage company focused on developing novel therapies for fibrotic diseases.See details»

KOP THERAPEUTICS

KOP Therapeutics is a Canadian biotech company headquartered in Vancouver BC. KOPโ€™s mission is to develop a non-toxic, affordable, targeted, immunotherapy-based mRNA drug for โ€ฆSee details»

Pi Therapeutics - Crunchbase Company Profile & Funding

Pi Therapeutics is a discovery-stage biopharmaceutical company aiming to develop a novel cancer drug. The company is financed by a syndicate of Takeda Pharmaceutical Company โ€ฆSee details»

linkstock.net © 2022. All rights reserved